Alzheimer Disease & Associated Disorders

Papers
(The median citation count of Alzheimer Disease & Associated Disorders is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-09-01 to 2024-09-01.)
ArticleCitations
Unraveling Ariadne’s Thread Into the Labyrinth of aMCI22
The Measurement of Everyday Cognition (ECog)19
Mild Alzheimer Disease, Financial Capacity, and the Role of Depression17
Effects of Noninvasive Brain Stimulation (NIBS) on Cognitive Impairment in Mild Cognitive Impairment and Alzheimer Disease15
Sociodemographic and Clinical Characteristics of 1350 Patients With Young Onset Dementia14
Racial/Ethnic Disparities in Young Adulthood and Midlife Cardiovascular Risk Factors and Late-life Cognitive Domains13
Predictors of Willingness to Enroll in Hypothetical Alzheimer Disease Biomarker Studies that Disclose Personal Results12
Bone Mineral Density Measurements and Association With Brain Structure and Cognitive Function12
Physical Performance and Cognition in a Diverse Cohort12
Patient and Relative Experiences and Decision-making About Genetic Testing and Counseling for Familial ALS and FTD11
Dementia Incidence in the Elderly Population of Greece11
Clinical Care and Unmet Needs of Individuals With Dementia With Lewy Bodies and Caregivers10
Prevalence of Mild Cognitive Impairment in the Lothian Birth Cohort 19369
Biomarker Use for Dementia With Lewy Body Diagnosis9
Cognitive Behavioral Therapy for Mood and Insomnia in Persons With Dementia9
Confluent White Matter in Progression to Alzheimer Dementia8
Intravesical BCG and Incidence of Alzheimer Disease in Patients With Bladder Cancer8
Assessment of Functional Near-infrared Spectroscopy by Comparing Prefrontal Cortex Activity8
Androgen Deprivation Therapy Use and Risk of Mild Cognitive Impairment in Prostate Cancer Patients8
Genetic Variants and Haplotypes of TOMM40, APOE, and APOC1 are Related to the Age of Onset of Late-onset Alzheimer Disease in a Colombian Population7
Outcome Measures for Dementia With Lewy Body Clinical Trials7
An Initial Empirical Operationalization of the Earliest Stages of the Alzheimer’s Continuum7
The Association Between Patterns of Social Engagement and Conversion From Mild Cognitive Impairment to Dementia7
Meta-analysis of the Connection Between Alzheimer Disease and Telomeres6
Do the Benefits of Educational Attainment for Late-life Cognition Differ by Racial/Ethnic Group?6
Association Between GlycA and Cognitive Function6
Early Impairment in the Ventral Visual Pathway Can Predict Conversion to Dementia in Patients With Amyloid-negative Amnestic Mild Cognitive Impairment6
Genetic Variants Associated With Alzheimer Disease in the 22 Arab Countries6
The Impact of Episodes of Lucidity on People Living With Dementia and Their Caregivers6
Long-term Neuropsychiatric Complications and 18F-FDG-PET Hypometabolism in the Brain From Prolonged Infection of COVID-196
Exercise and the Risk of Mild Cognitive Impairment6
Phase 1 Single Ascending and Multiple Ascending Dose Studies of Phosphodiesterase-9 Inhibitor E20276
Effects of Depression on Changes in Cognitive Function in Older Adults6
Functional Decline and Body Composition Change in Older Adults With Alzheimer Disease6
Beliefs, Understanding, and Barriers Related to Dementia Research Participation Among Older African Americans6
Right Temporal Lobe Variant of Frontotemporal Dementia6
Association Between Adherence to the MIND Diet and Cognitive Performance is Affected by Income5
Using Direct-to-Consumer Genetic Testing Results to Accelerate Alzheimer Disease Clinical Trial Recruitment5
Impact of Disturbed Rest-activity Rhythms on Activities of Daily Living in Moderate and Severe Dementia Patients5
Obesity and Oxidative Stress in Older Adults At Risk for Dementia5
Clinical Profiles of Arteriolosclerosis and Alzheimer Disease at Mild Cognitive Impairment and Mild Dementia in a National Neuropathology Cohort5
Cerebral Amyloid Angiopathy-related Inflammation Presenting With a Cystic Lesion in Young-onset Alzheimer Disease5
Predicting Mental Decline Rates in Mild Cognitive Impairment From Baseline MRI Volumetric Data5
Perceptions of Research Burden and Retention Among Participants in ADRC Cohorts5
Polymorphism in the MAGI2 Gene Modifies the Effect of Amyloid β on Neurodegeneration5
Limited Longitudinal Change in Self-reported Spatial Navigation Ability in Preclinical Alzheimer Disease4
Familiarity in Mild Cognitive Impairment as a Function of Patients’ Clinical Outcome 4 Years Later4
Engaging Diverse Older Adults With Cognitive Impairment and Caregivers in Advance Care Planning4
Evolving Causes of Rapidly Progressive Dementia4
Tailoring Research Recruitment for Acute Care Settings4
Novel PSEN1 and PSEN2 Mutations Identified in Sporadic Early-onset Alzheimer Disease and Posterior Cortical Atrophy4
The Relationship Between Decision-making Capacity and the Domains of Awareness in Alzheimer Disease4
Changes in Polypharmacy and Psychotropic Medication Use After Diagnosis of Major Neurocognitive Disorders4
Temporal Speech Parameters Indicate Early Cognitive Decline in Elderly Patients With Type 2 Diabetes Mellitus4
Subtle Changes in Medication-taking Are Associated With Incident Mild Cognitive Impairment4
Carotid Intima-Media Thickness (cIMT) and Cognitive Performance4
Role of Apolipoprotein E in the Clinical Profile of Atypical Parkinsonian Syndromes4
Evaluation of the Clinical Features Accompanied by the Gene Mutations4
Does a Cancer Diagnosis in Mid-to-Later Life Modify Racial Disparities in Memory Aging?4
Postsecondary Education and Late-life Cognitive Outcomes Among Black and White Participants in the Project Talent Aging Study3
Novel Presenilin-1 Mutation (Ala275Ser) Associated With Clinical Features of Dementia With Lewy Bodies3
Effect of Neurotoxin Exposure on Blood Biomarkers of Neurodegeneration and Alzheimer Disease3
Examining the Role of Aging Perceptions in Subjective Cognitive Decline3
Impaired Color Discrimination in Alzheimer Disease Dementia3
Research Priorities of Individuals and Caregivers With Lewy Body Dementia3
Musical Bridges to Memory3
Alzheimer’s Disease Neuropathologic Change and Vitamin Supplement Use Decades Earlier3
β-Amyloid Orchestrates Factor XII and Platelet Activation Leading to Endothelial Dysfunction and Abnormal Fibrinolysis in Alzheimer Disease3
Family Caregiver Comorbidities in Lewy Body Dementia Versus Alzheimer Disease and Associated Disorders3
Apolipoprotein E4 Moderates the Association Between Vascular Risk Factors and Brain Pathology3
Pure Prosodic Type of Primary Progressive Apraxia of Speech Mimicking Nonfluent Aphasia and Later Progressing to Corticobasal Syndrome3
Physical Exercise as a Nonpharmacological Intervention for the Treatment of Neuropsychiatric Symptoms in Persons With Dementia3
CSF α-Synuclein and Tau as Biomarkers for Dementia With Lewy Bodies3
Gray Matter Volume as Evidence for Cognitive Reserve in Bilinguals With Mild Cognitive Impairment3
Healthy Lifestyle Behaviors and Viewpoints Among Members of an Alzheimer Prevention Registry3
Alzheimer Disease Worries, Fears, and Stigma and Their Relationship to Genetic and Interventional Research Engagement3
Brain 18F-Florbetapir PET/CT Findings in an Early-onset Alzheimer Disease Patient Carrying Presenilin-1 G378E Mutation3
Psychological Impact of Predictive Genetic Testing for Inherited Alzheimer Disease and Frontotemporal Dementia3
Predictors of Cognitive Change in Parkinson Disease3
Interaction of Alzheimer Disease and Traumatic Brain Injury on Cortical Thickness2
Impact of COVID-19 Pandemic on Research Participation Among Older African Americans2
An Agitated Patient With COVID-19 Infection and Early-onset Alzheimer Disease2
Driving Habits of Older Adults2
Impaired Emotion Recognition: A Potential Marker for Social Behavioral Problems in Patients With Amnestic Mild Cognitive Impairment and Early Alzheimer Disease?2
Psychometric Properties of the ICECAP-O Quality of Life Measurement Tool When Self-reported by Community-dwelling Older People With Mild and Moderate Dementia2
Validation of the Short Version of the 10/66 Dementia Diagnosis in Urdu in Karachi, Pakistan2
Early-onset Alzheimer Disease Associated With Neuromyelitis Optica Spectrum Disorder2
A Model to Assess the Outcomes Associated With Dementia With Lewy Bodies2
Education as a Moderator of Help Seeking Behavior in Subjective Cognitive Decline2
Balance and Gait2
A Visual Analog Scale for Self-Reported Quality of Life2
Factors Associated With Sleep Quality in Hospitalized Persons With Dementia2
In Individuals With Subjective Cognitive Decline, Age, Memory and Speed Scores at Baseline Predict Progression to Cognitive Impairment2
Everyday Abilities Scale for India in Screening for Poststroke Dementia Among Young Stroke Survivors2
Economic Burden of Chronic Comorbidities Among Community-Dwelling Older Adults With Dementia2
GAD65 Autoimmune Encephalitis2
Proteomic Analysis Reveals Potential Exosomal Biomarkers in Patients With Sporadic Alzheimer Disease2
Decreased Expression of Cerebral Dopamine Neurotrophic Factor in Platelets of Probable Alzheimer Patients2
Direct Mail Recruitment to a Potential Participant Registry2
Computer-based Eye-tracking Analysis of King-Devick Test Differentiates Persons With Idiopathic Normal Pressure Hydrocephalus From Cognitively Unimpaired2
Association of Being Accompanied at Medical Consultation and Having Memory Complaints With Cognitive Impairment in Elderly Brazilian Outpatients2
Psychosocial and Behavioral Outcomes for Persons With Cognitive Impairment and Caregivers Following Amyloid-β PET Scan Disclosure2
Comparing Performance of Different Predictive Models in Estimating Disease Progression in Alzheimer Disease2
Screening for Dementia and Cognitive Decline in Adults With Down Syndrome2
Met and Unmet Needs of Older Adults With Cognitive Impairment, and Burden and Benefits of Their Family Caregivers2
A New and Tidier Setting2
Development and Validation of a Multidimensional Short Version Zarit Burden Interview (ZBI-9) for Caregivers of Persons With Cognitive Impairment2
Exploring Social Cognition Tests to Differentiate Frontotemporal Dementia from Depression2
Perspectives From Black and White Participants and Care Partners on Return of Amyloid and Tau PET Imaging and Other Research Results2
The Impact of Amyloid PET Disclosure on Quality of Life in Patients With Young Onset Dementia2
Increasing the Cognitive Screening Efficiency of Global Phase III Trials in Early Alzheimer Disease1
Anticipated Psychological or Behavioral Reactions to Learning Alzheimer Biomarker Results1
Gender, Pain, and Function Associated With Physical Activity After Hospitalization in Persons Living With Dementia1
The “Sickness” Memory1
A Comparison of Methods for Predicting Future Cognitive Status1
Cause of Death Determined by Full-body Autopsy in Neuropathologically Diagnosed Dementias1
Application of Suggestive Biomarkers in Dementia With Lewy Bodies With Masking of Typical Clinical Symptoms by Alzheimer Disease-type Pathology1
Providing a Purposeful and Stimulating Volunteer Opportunity for Older Adults With Mild Cognitive Impairment1
A Virtual Photovoice Study of Older African Americans Perceptions of Neurovascular Clinical Trials1
The Technology in Caring Questionnaire1
Assessing how Age, Sex, Race, and Education Affect the Relationships Between Cognitive Domains and Odor Identification1
A Pilot Randomized Trial of a Purposeful and Stimulating Volunteer Opportunity1
Remuneration and Recruitment of Study Participants for AD Cohort Studies From the General Public and From Minority Communities1
A Randomized Double-blind Study to Assess the Skin Irritation and Sensitization Potential of a Once-weekly Donepezil Transdermal Delivery System in Healthy Volunteers1
Assessing Social Cognition in Older Adults1
Relapse in Dementia-related Psychosis and Clinical Decisions1
A Transformer Approach for Cognitive Impairment Classification and Prediction1
A National Assessment of Alzheimer Disease and Antipsychotic Medication Prescribing Among Older Adults in Ambulatory Care Settings1
MoCA Intraindividual Cognitive Variability in Older Adults With Type 1 Diabetes1
Dementia and Related Comorbidity1
Activities of Daily Living Performance in Persons With Dementia1
Predictors of Driving Cessation in Older Adults1
Adapting Alzheimer Disease and Related Dementias Clinical Research Evaluations in the Age of COVID-191
Odor Identification Testing Can Assist in the Clinical Distinction Between Psychiatric Disorders and Neurological/Neurodegenerative Disorders1
Comparison of Enlarged Perivascular Spaces in Early-Onset and Late-Onset Alzheimer Disease-related Cognitive Impairment1
Utility of the Repeat and Point Test for Subtyping Patients With Primary Progressive Aphasia1
Regional White Matter Hyperintensities Relate to Specific Cognitive Abilities in Older Adults Without Dementia1
Development of a Comprehensive Battery to Collect Social and Structural Determinants of Health (SSDOH) in Cognitively Normal or Very Mildly Impaired Persons1
Caring for the Caregivers1
A Case of Corticobasal Syndrome and Posterior Cortical Atrophy With Biomarkers of Alzheimer Disease1
Evidence of Pericyte Damage in a Cognitively Normal Cohort1
Atypical Young-onset Dementia in Cerebral Thromboangiitis Obliterans1
Dyadic Enrollment in a Phase 3 Mild Cognitive Impairment Clinical Trial1
Cognitive Impairment and the Associated Factors Among Older People in Rural Central Tanzania1
A National Assessment of Alzheimer Disease and Antipsychotic Medication Prescribing Among Older Adults in Ambulatory Care Settings1
Trends in Alzheimer Disease Mortality Among American Indian and Alaska Native People Between 2011 and 20191
Alzheimer Disease: A New Beginning in Therapeutics1
0.032446146011353